Review: Methods for Enhancing Solubility of Carvedilol

Iyan Sopyan, Rania Talinta L, Nurdiani Adiningsih, Norisca Aliza Putriana, Sandra Megantara2 Megantara

Abstract

The oral route of administration is the most frequently used route of drug administration and is generally the most convenient for patients. For an oral drug to be effective, a therapeutic concentration in the blood must be achieved. Solubility in water and permeability of active pharmaceutical ingredients are often used as the main conditions for rapid and complete absorption and high bioavailability. Carvedilol is beta blockers that works as an antihypertensive drug and included in biopharmaceutical classification system (BCS) class II with high permeability but low solubility. Due to this, the goal of this review is to go through a few different methods for increasing solubility of carvedilol. dissolution, and bioavailability. Various solubility enhancement techniques have been applied to carvedilol, including co-crystallization, liquidsolid technique, cyclodextrin inclusion complex, nanoparticles, hydrotrophy, nanosuspension, solid dispersion, nanoemulsion, and dendrimers. These techniques have been shown to increase the solubility and dissolution rate of carvedilol thereby increasing its bioavailability.

Keyword: carvedilol, solubility enhancement, BCS class II

Full Text:

PDF HTML

References

Arregui JR, Kovvasu SP, Kunamaneni P, Betageri GV. Carvedilol solid dispersion for enhanced oral bioavailability using rat model. J Appl Pharm Sci. 2019;9:42–50.

Kraisit P. Impact of hydroxypropyl methylcellulose (HPMC) type and concentration on the swelling and release properties of propranolol hydrochloride matrix tablets usning a simplex centroid design. Int J Appl Pharm. 2019;11:143–51.

Ahad A, Al-Saleh AA, Akhtar N, Al-Mohizea AM, Al-Jenoobi FI. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies. Drug Discov Today. 2015 Oct;20(10):1217–27.

Lee EH. A practical guide to pharmaceutical polymorph screening & selection. Asian J Pharm Sci. 2014 Aug;9(4):163–75.

Eesam S, Bhandaru JS, Naliganti C, Bobbala RK, Akkinepally RR. Solubility enhancement of carvedilol using drug–drug cocrystallization with hydrochlorothiazide. Future J Pharm Sci. 2020;6(1):1–13.

Jamakandi VG. Formulation and evaluation of immediate release tablet of carvedilol using liquisolid compacts technique for solubility enhancement. Asian J Pharm AJP Free Full Text Artic Asian J Pharm. 2016;10(03).

Rigaud S, Mathiron D, Moufawad T, Landy D, Djedaini-Pilard F, Marçon F. Cyclodextrin Complexation as a Way of Increasing the Aqueous Solublity and Staility of Carvedilol. Pharmaceutics. 2021;13(11):1746.

Thenge R, Patel R, Kayande N, Mahajan N. Co-crystals of carvedilol: preparation, characterization and evaluation. Int J Appl Pharm. 2020;12:42–9.

Zoghbi A, Geng T, Wang B. Dual activity of hydroxypropyl-β-cyclodextrin and water-soluble carriers on the solubility of carvedilol. Aaps Pharmscitech. 2017;18(8):2927–35.

Khan AD, Singh L. Various techniques of bioavailability enhancement: a review. J Drug Deliv Ther. 2016;6(3):34–41.

Liu R. Water-Insoluble Drug Formulation, Second Edition. CRC Press; 2008. 686 p.

Sharma M, Sharma R, Jain DK, Saraf A. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study. Int J Biol Macromol. 2019;135:246–60.

Numata M, Shinkai S. ‘Supramolecular wrapping chemistry’by helix-forming polysaccharides: a powerful strategy for generating diverse polymeric nano-architectures. Chem Commun. 2011;47(7):1961–75.

Alatas F, Soewandhi S, Sasongko L, Ismunandar, Uekusa H. Cocrystal formation between didanosine and two aromatic acids. Int J Pharm Pharm Sci. 2013;5:275–80.

Agustiani RD. Peningkatan kelarutan dan laju disolusi glimepirid dengan koformer asam malonat melalui metode kokristalisasi dan kimia komputasi. 2015;

Al-Kazemi R, Al-Basarah Y, Nada A. Dissolution enhancement of atorvastatin calcium by cocrystallization. Adv Pharm Bull. 2019;9(4):559.

Dutt B, Choudhary M, Budhwar V. Preparation, characterization and evaluation of aspirin: benzoic acid cocrystals with enhanced pharmaceutical properties. Future J Pharm Sci. 2020;6(1):1–16.

Fernandes GJ, Kumar L, Sharma K, Tunge R, Rathnanand M. A review on solubility enhancement of carvedilol—a BCS class II drug. J Pharm Innov. 2018;13(3):197–212.

Guo J, Fu K, Zhang Z, Yang L, Huang YC, Huang CI, et al. Reversible thermochromism via hydrogen-bonded cocrystals of polydiacetylene and melamine. Polymer [Internet]. 2016 Oct 5 [cited 2016 Oct 5]; Available from: http://www.sciencedirect.com/science/article/pii/S0032386116306012

Guo M, Sun X, Chen J, Cai T. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications. Acta Pharm Sin B. 2021;11(8):2537–64.

Chun NH, Wang IC, Lee MJ, Jung YT, Lee S, Kim WS, et al. Characteristics of indomethacin–saccharin (IMC–SAC) co-crystals prepared by an anti-solvent crystallization process. Eur J Pharm Biopharm. 2013 Nov;85(3, Part B):854–61.

Rodrigues M, Baptista B, Lopes JA, Sarraguça MC. Pharmaceutical cocrystallization techniques. Advances and challenges. Int J Pharm. 2018;547(1–2):404–20.

Wang CH, Chang CJ, Wu JJ, Lee GB. An integrated microfluidic device utilizing vancomycin conjugated magnetic beads and nanogold-labeled specific nucleotide probes for rapid pathogen diagnosis. Nanomedicine Nanotechnol Biol Med. 2014 May 1;10(4):809–18.

Sapana BB, Shashikant DN. Preparation and characterisation of [beta]-cyclodextrin nebivolol inclusion complex. Int J Pharm Sci Res. 2015;6(5):2205.

Venishetty VK, Chede R, Komuravelli R, Adepu L, Sistla R, Diwan PV. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B Biointerfaces. 2012;95:1–9.

Sharma M, Sharma R, Jain DK, Saraf A. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study. Int J Biol Macromol. 2019;135:246–60.

Sajid MA, Choudhary V. Solubility enhancement methods with importance of hydrotropy. J Drug Deliv Ther. 2012;2(6):96–101.

Liu D, Pan H, He F, Wang X, Li J, Yang X, et al. Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation. Int J Nanomedicine. 2015;10:6425.

Lee MJ, Chun NH, Wang IC, Liu JJ, Jeong MY, Choi GJ. Understanding the Formation of Indomethacin–Saccharin Cocrystals by Anti-Solvent Crystallization. Cryst Growth Des. 2013;13(5):2067–74.

Sharma D. Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate for Respiratory Disorders. Int Sch Res Not. 2013 Jul 15;2013:e674507.

Kumar B. Solid dispersion-a review. PharmaTutor. 2017;5(2):24–9.

Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 2019;11(3):132.

Rajeswari S, Bhanu K, Panda S, Swain RP, Ramana Murthy KV, Kudamala S. Solid dispersion: An evergreen solubility enhancement technique for hydrophobic drugs. J Chem Pharm Res. 2016;8(4):1218–28.

Allawadi D, Singh N, Singh S, Arora S. Solid dispersions: a review on drug delivery system and solubility enhancement. ChemInform. 2014;45(18):no-no.

Jasmina H, Džana O, Alisa E, Edina V, Ognjenka R. Preparation of nanoemulsions by high-energy and lowenergy emulsification methods. In: CMBEBIH 2017. Springer; 2017. p. 317–22.

Madaan K, Kumar S, Poonia N, Lather V, Pandita D. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci. 2014;6(3):139.

Sharma M, Sharma R, Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica. 2016;2016.

Gautam SP, Verma A. PAMAM dendrimers: novel polymeric nanoarchitectures for solubility enhancement of candesartan cilexetil. Pharm Sci. 2012;1:1–4.

DOI: https://doi.org/10.24198/idjp.v4i1.39321

Refbacks

  • There are currently no refbacks.